BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cai HJ, Fang JH, Kong FL, Xu CK, Chen CH, Wang W, Huang B. Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy. Acta Radiol 2022;63:553-8. [PMID: 33779301 DOI: 10.1177/02841851211003289] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Sessa F, Polverino P, Siena G, Bisegna C, Lo Re M, Spatafora P, Pecoraro A, Rivetti A, Moscardi L, Saladino M, Cocci A, Gacci M, Li Marzi V, Carini M, Minervini A, Campi R, Serni S. Transperineal Laser Ablation of the Prostate (TPLA) for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction. JCM 2023;12:793. [DOI: 10.3390/jcm12030793] [Reference Citation Analysis]
2 Chen L, Zhang W, Meng Z, Guo Q, Cao N, Xu Y, Fu Q, Hu B. Efficacy and safety of ultrasonography guided transperineal percutaneous laser ablation for treating benign prostatic hyperplasia: a randomized controlled trial.. [DOI: 10.21203/rs.3.rs-2433606/v1] [Reference Citation Analysis]
3 Cai H, Zhu C, Fang J. Ultrasound-guided perineal laser ablation versus prostatic arterial embolization for benign prostatic hyperplasia: two similar short-term efficacies. Acta Radiol 2022. [DOI: 10.1177/02841851221140214] [Reference Citation Analysis]
4 Sessa F, Bisegna C, Polverino P, Gacci M, Siena G, Cocci A, Marzi VL, Minervini A, Serni S, Campi R. Transperineal laser ablation of the prostate (TPLA) for selected patients with lower urinary tract symptoms due to benign prostatic obstruction: a step-by-step guide. Urology Video Journal 2022;15:100167. [DOI: 10.1016/j.urolvj.2022.100167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sessa F, Polverino P, Bisegna C, Siena G, Lo Re M, Spatafora P, Pecoraro A, Rivetti A, Conte FL, Cocci A, Villari D, Minervini A, Gacci M, Li Marzi V, Serni S, Campi R. Transperineal laser ablation of the prostate with EchoLaser™ system: perioperative and short-term functional and sexual outcomes. Front Urol 2022;2. [DOI: 10.3389/fruro.2022.969208] [Reference Citation Analysis]
6 Franz J, Gratzke C, Miernik A. [Minimally Invasive Therapy: What Is The Status In 2021 - What's Coming, What's Going?]. Aktuelle Urol 2022;53:231-9. [PMID: 35231939 DOI: 10.1055/a-1702-8150] [Reference Citation Analysis]
7 Zhang W, Zhang W, Guo Q, Chen L, Meng Z, Xu Y, Cao N, Hu B, Qian B. The Design and Rationale of a Multicentre Randomised Controlled Trial Comparing Transperineal Percutaneous Laser Ablation With Transurethral Resection of the Prostate for Treating Benign Prostatic Hyperplasia. Front Surg 2021;8:755957. [PMID: 34733883 DOI: 10.3389/fsurg.2021.755957] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Manenti G, Perretta T, Calcagni A, Ferrari D, Ryan CP, Fraioli F, Meucci R, Malizia A, Iacovelli V, Agrò EF, Floris R. 3-T MRI and clinical validation of ultrasound-guided transperineal laser ablation of benign prostatic hyperplasia. Eur Radiol Exp 2021;5:41. [PMID: 34532768 DOI: 10.1186/s41747-021-00239-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]